Challenges of Maintenance Tyrosine Kinase Inhibitor Therapy after Allogeneic Hematopoietic Cell Transplantation in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

被引：0

作者：

Othman, Tamer ^{[1
,2
]}

Koller, Paul B. ^{[3
]}

Tsai, Ni-Chun ^{[4
]}

Pourhassan, Hoda ^{[3
]}

Agrawal, Vaibhav ^{[2
]}

Otoukesh, Salman ^{[3
]}

Amanam, Idoroenyi ^{[3
]}

Ngo, Dat ^{[5
]}

Chen, Jason ^{[5
]}

Al Malki, Monzr M. ^{[3
]}

Salhotra, Amandeep ^{[3
]}

Ali, Haris ^{[3
]}

Aribi, Ahmed ^{[3
]}

Sandhu, Karamjeet S. ^{[3
]}

Arslan, Shukaib ^{[3
]}

Ball, Brian J. ^{[3
]}

Stewart, Forrest M. ^{[3
]}

Curtin, Peter T. ^{[3
]}

Artz, Andrew S. ^{[3
]}

Snyder, David S. ^{[2
]}

Marcucci, Guido ^{[3
]}

Forman, Stephen J. ^{[3
]}

Stein, Anthony S. ^{[3
]}

Nakamura, Ryotaro ^{[2
]}

Pullarkat, Vinod A. ^{[3
]}

Aldoss, Ibrahim ^{[3
]}

Mei, Matthew ^{[6
]}

机构：

[1] Univ Calif Davis, Comprehens Canc Ctr, Sacramento, CA 95817 USA

[2] City Hope Natl Med Ctr, Dept Hematol & Hematopoiet Cell Transplantat, Duarte, CA USA

[3] City Hope Natl Med Ctr, Dept Hematol & Hematopoiet Cell Transplantat, 1500 E Duarte Rd, Duarte, CA 91010 USA

[4] City Hope Natl Med Ctr, Dept Computat & Quantitat Med BRI, 1500 E Duarte Rd, Duarte, CA 91010 USA

[5] City Hope Natl Med Ctr, Dept Pharm, 1500 E Duarte Rd, Duarte, CA 91010 USA

[6] City Hope Med Ctr, Dept Hematol & Hematopoiet Cell Transplantat, Duarte, CA USA

来源：

BLOOD | 2022年 / 140卷

关键词：

D O I：

10.1182/blood-2022-164639

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：4821 / 4822

页数：2

共 50 条

[1] Prophylactic or preemptive tyrosine kinase inhibitor therapy after allogeneic hematopoietic cell transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia
Nakasone, Hideki
INTERNATIONAL JOURNAL OF HEMATOLOGY, 2023, 118 (02) : 183 - 192
[2] Prophylactic or preemptive tyrosine kinase inhibitor therapy after allogeneic hematopoietic cell transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia
Hideki Nakasone
International Journal of Hematology, 2023, 118 : 183 - 192
[3] Tyrosine Kinase Inhibitor Treatment after Allogeneic Hematopoietic Stem Cell Transplantation for Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia
Chang, Yu-Hsiang
Liao, Xiu-Wen
Liu, Jia-Hau
Yao, Ming
Ko, Bor-Sheng
Li, Chi-Cheng
Tsai, Cheng-Hong
Wu, Shang-Ju
Huang, Hui-Hsuan
Huang, Tai-Chung
Hou, Hsin-An
Chou, Wen-Chien
Tien, Feng-Ming
Lin, Yun-Chu
Lu, Meng-Yao
Lin, Kai-Hsin
Tang, Jih-Luh
BONE MARROW TRANSPLANTATION, 2020, 55 (SUPPL 1) : 201 - 202
[4] Toxicities associated with tyrosine kinase inhibitor maintenance following allogeneic hematopoietic cell transplantation in Philadelphia chromosome-positive acute lymphoblastic leukemia
Othman, Tamer
Koller, Paul
Tsai, Ni-Chun
Yang, Dongyun
Pourhassan, Hoda
Agrawal, Vaibhav
Ngo, Dat
Chen, Jason
Farol, Leonardo
Spielberger, Ricardo
Sahebi, Firoozeh
Al Malki, Monzr M.
Cai, Ji-Lian
Sandhu, Karamjeet S.
Mansour, Joshua
Salhotra, Amandeep
Ali, Haris
Aribi, Ahmed
Arslan, Shukaib
Marcucci, Guido
Forman, Stephen J.
Stein, Anthony S.
Nakamura, Ryotaro
Pullarkat, Vinod
Aldoss, Ibrahim
Mei, Matthew
AMERICAN JOURNAL OF HEMATOLOGY, 2024, 99 (09) : 1680 - 1690
[5] Toxicities Associated with Tyrosine Kinase Inhibitor Maintenance Following Allogeneic Hematopoietic Cell Transplantation in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
Othman, Tamer
Koller, Paul B.
Tsai, Ni-Chun
Ngo, Dat
Chen, Jason
Blackmon, Amanda
Pourhassan, Hoda
Agrawal, Vaibhav
Amanam, Idoroenyi
Ball, Brian J.
Otoukesh, Salman
Salhotra, Amandeep
Arslan, Shukaib
Al Malki, Monzr M.
Ali, Haris
Sandhu, Karamjeet S.
Aribi, Ahmed
Artz, Andrew
Stewart, Forest Marc
Smith, Eileen Patricia
Stein, Anthony
Marcucci, Guido
Nakamura, Ryotaro
Pullarkat, Vinod
Aldoss, Ibrahim
Mei, Matthew Genyeh
BLOOD, 2023, 142
[6] Maintenance therapy with dasatinib after allogeneic hematopoietic stem cell transplantation in Philadelphia chromosome-positive acute lymphoblastic leukemia
Teng, Chieh-Lin Jerry
Yu, Jui-Ting
Chen, Hung-Chieh
Hwang, Wen-Li
ANNALS OF HEMATOLOGY, 2013, 92 (08) : 1137 - 1139
[7] Maintenance therapy with dasatinib after allogeneic hematopoietic stem cell transplantation in Philadelphia chromosome-positive acute lymphoblastic leukemia
Chieh-Lin Jerry Teng
Jui-Ting Yu
Hung-Chieh Chen
Wen-Li Hwang
Annals of Hematology, 2013, 92 : 1137 - 1139
[8] Efficacy and safety of olverembatinib as maintenance therapy after allogeneic hematopoietic cell transplantation in Philadelphia chromosome-positive acute lymphoblastic leukemia
Kong, Jun
Zheng, Feng-Mei
Yan, Chen-Hua
Wang, Jing-Zhi
Fu, Hai-Xia
Wang, Zhi-Dong
Suo, Pan
Hu, Guan-Hua
Lv, Meng
Chen, Huan
Mo, Xiao-Dong
Xu, Lan-Ping
Zhang, Xiao-Hui
Huang, Xiao-Jun
Wang, Yu
ANNALS OF HEMATOLOGY, 2025, 104 (01) : 801 - 808
[9] Tyrosine Kinase Inhibitor Followed by Cart Therapy for the Treatment of Relapsed Philadelphia chromosome-positive B-cell Acute Lymphoblastic Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation
Lin, Yuehui
Deng, Biping
Yin, Zhichao
An, Lihong
Zhao, Defeng
Liu, Dan
BONE MARROW TRANSPLANTATION, 2020, 55 (SUPPL 1) : 264 - 265
[10] The impact of tyrosine kinase inhibitors on allogeneic hematopoietic stem cell transplantation for adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia
Zhang, Yuanfeng
Feng, Sizhou
LEUKEMIA RESEARCH, 2021, 109

← 1 2 3 4 5 →